Myocardial Injury in Adults Hospitalized With COVID-19
Nathaniel R. Smilowitz(VA NY Harbor Healthcare System), Jeffrey S. Berger(New York University), Louai Razzouk(Anna Needs Neuroblastoma Answers), Siddhant Dogra(New York University), Glenn I. Fishman(New York University), Adriana Quiñones‐Camacho(Anna Needs Neuroblastoma Answers), Carlos L. Alviar(New York University), Yindalon Aphinyanaphongs(NYU Langone Health), Judith S. Hochman(New York University), Ruina Zhang(NYU Langone Health), Ji Chen(NYU Langone Health), Neil Jethani(NYU Langone Health), Norma Keller(Anna Needs Neuroblastoma Answers), Albert Jung(Anna Needs Neuroblastoma Answers)
Cited by 44
Related Papers
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy
|Journal of the American College of Cardiology|2003|1.6k
Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19
|New England Journal of Medicine|2020|1.1k
Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry
|The Lancet|2020|945
ST-Segment Elevation in Patients with Covid-19 — A Case Series
|New England Journal of Medicine|2020|858
Ischemia and No Obstructive Coronary Artery Disease (INOCA)
|Circulation|2017|745